Section menu +

Selegiline hydrochloride

Selegiline hydrochloride is an active ingredient that is used in some medicines.

The active ingredient is the chemical in a medicine that makes it work. Medicines can have more than one active ingredient and be available under different brand names. Medicines include both active ingredients and inactive ingredients.

This page about
selegiline hydrochloride
automatically lists related information collected from other pages of our website.

Consumers: If you have any questions about medicines, you can speak to one of our pharmacists at NPS Medicines Line by calling 1300 633 424. You can ring Monday to Friday, 9 am to 5 pm, Australian Eastern Standard Time (excluding NSW public holidays). For non-medicine products, further information may also be available from the manufacturer.

Related information - selegiline hydrochloride

11 Dec2014 –
Eldepryl Tablets is a brand of medicine containing the active ingredient selegiline hydrochloride. Find out about side effects, who can take it and who shouldn’t use Eldepryl Tablets by reading the latest Australian consumer medicine information, plus tips on how to use medicines wisely and safely.

11 Dec2014 –
Selgene Tablets is a brand of medicine containing the active ingredient selegiline hydrochloride. Find out about side effects, who can take it and who shouldn’t use Selgene Tablets by reading the latest Australian consumer medicine information, plus tips on how to use medicines wisely and safely.

20 May2014 –
Medicines are the mainstay of treatment, to increase the amount or effect of dopamine in the brain. Many different types of medicine are used and each type works in a slightly different way.

Reasonable care is taken to provide accurate information at the time of creation. This information is not intended as a substitute for medical advice and should not be exclusively relied on to manage or diagnose a medical condition. NPS MedicineWise disclaims all liability (including for negligence) for any loss, damage or injury resulting from reliance on or use of this information. Read our full disclaimer.